Randomized double-blind placebo-controlled trial of 40 mg/day of atorvastatin in reducing the severity of sepsis in ward patients (ASEPSIS Trial). [electronic resource]
Producer: 20150930Description: R231 p. digitalISSN:- 1466-609X
- Anti-Inflammatory Agents -- administration & dosage
- Atorvastatin
- Disease Progression
- Double-Blind Method
- Female
- Heptanoic Acids -- administration & dosage
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- administration & dosage
- Length of Stay -- statistics & numerical data
- Male
- Middle Aged
- Patient Readmission -- statistics & numerical data
- Pyrroles -- administration & dosage
- Sepsis -- drug therapy
- Severity of Illness Index
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.